tetracosahexaenoic-acid and Leukemia--T-Cell

tetracosahexaenoic-acid has been researched along with Leukemia--T-Cell* in 1 studies

Other Studies

1 other study(ies) available for tetracosahexaenoic-acid and Leukemia--T-Cell

ArticleYear
Exogenous tetracosahexaenoic acid modifies the fatty acid composition of human primary T lymphocytes and Jurkat T cell leukemia cells contingent on cell type.
    Lipids, 2023, Volume: 58, Issue:4

    Tetracosahexaenoic acid (24:6ω-3) is an intermediate in the conversion of 18:3ω-3 to 22:6ω-3 in mammals. There is limited information about whether cells can assimilate and metabolize exogenous 24:6ω-3. This study compared the effect of incubation with 24:6ω-3 on the fatty acid composition of two related cell types, primary CD3

    Topics: Animals; Docosahexaenoic Acids; Fatty Acids; Humans; Jurkat Cells; Leukemia, T-Cell; Mammals

2023